R. Macarron

Molecular Biology · 2006–2011

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom R. Macarron trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Butler

Who trusts R. Macarron overall

  1. D. Newman
  2. G. Cragg
  3. Philip J. Hajduk

Papers from R. Macarron's perspective

Ordered by how strongly the researchers R. Macarron trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Is There a Difference between Leads and Drugs? A Historical Perspective (Journal of chemical information and computer sciences)
  2. How to improve R&D productivity: the pharmaceutical industry's grand challenge
  3. Drug repositioning: identifying and developing new uses for existing drugs (Nature reviews. Drug discovery)
  4. Do structurally similar molecules have similar biological activity? (Journal of Medicinal Chemistry)
  5. Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry,…
  6. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect (Nature)
  7. The druggable genome (Nature reviews. Drug discovery)
  8. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
  9. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
  10. PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (Journal of Lipid Research)

Their papers